Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 43, 2008 - Issue 11
Submit an article Journal homepage
132
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

Eliya Syed Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
,
Nogol Rahbin Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
,
Ola Weiland Department of Infectious Diseases, Karolinska University Hospital, Sweden
,
Tony Carlsson Department of Infectious Diseases, Karolinska University Hospital, Sweden
,
Antti Oksanen Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
,
Markus Birk Department of Virology, Karolinska University Hospital, Sweden
,
Loa Davidsdottìr Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
,
Karin Hagen Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
,
Rolf Hultcrantz Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
&
Soo Aleman Department of Gastroenterology and Hepatology, Karolinska University Hospital, SwedenCorrespondence[email protected]
, PhD , MD show all
Pages 1378-1386 | Received 17 Mar 2008, Published online: 08 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ann-Sofi Duberg, Sarah Blach, Karolin Falconer, Martin Kåberg, Homie Razavi & Soo Aleman. (2015) The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies. Scandinavian Journal of Gastroenterology 50:2, pages 233-244.
Read now
Angelo Iacobellis & Angelo Andriulli. (2009) Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection. Expert Opinion on Pharmacotherapy 10:12, pages 1929-1938.
Read now
Jørn Brynskov. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:11, pages 1283-1284.
Read now

Articles from other publishers (13)

Marcus Höring, Georg Peschel, Jonathan Grimm, Sabrina Krautbauer, Martina Müller, Kilian Weigand, Gerhard Liebisch & Christa Buechler. (2022) Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection. International Journal of Molecular Sciences 23:17, pages 9806.
Crossref
Chang Ho Jung, Soon Ho Um, Tae Hyung Kim, Sun Young Yim, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Hyuk Soon Choi & Hoon Jai Chun. (2016) Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C. Gut and Liver 10:5, pages 808-817.
Crossref
Nobuhiro Aizawa, Hirayuki Enomoto, Tomoyuki Takashima, Yoshiyuki Sakai, Kazunari Iwata, Naoto Ikeda, Hironori Tanaka, Yoshinori Iwata, Masaki Saito, Hiroyasu Imanishi, Hiroko Iijima & Shuhei Nishiguchi. (2013) Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Journal of Gastroenterology 49:8, pages 1253-1263.
Crossref
Kanda Tatsuo, Yokosuka Osamu & Omata Masao. (2013) Antiviral therapy for “difficult-to-treat” hepatitis C virus-infected patients. Chinese Medical Journal 126:23, pages 4568-4574.
Crossref
Soo Aleman, Nogol Rahbin, Ola Weiland, Loa Davidsdottir, Magnus Hedenstierna, Nina Rose, Hans Verbaan, Per Stål, Tony Carlsson, Hans Norrgren, Anders Ekbom, Fredrik Granath & Rolf Hultcrantz. (2013) A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis. Clinical Infectious Diseases 57:2, pages 230-236.
Crossref
Simona Bota, Ioan Sporea, Roxana Şirli, Adriana Maria Neghină, Alina Popescu & Mihnea Străin. (2013) Role of Interleukin-28B Polymorphism as a Predictor of Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Triple Therapy: A Systematic Review and Meta-Analysis. Clinical Drug Investigation 33:5, pages 325-331.
Crossref
Savino Bruno, John M. Vierling, Rafael Esteban, Lisa M. Nyberg, Hugo Tanno, Zachary Goodman, Fred Poordad, Bruce Bacon, Keith Gottesdiener, Lisa D. Pedicone, Janice K. Albrecht, Clifford A. Brass, Seth Thompson & Margaret H. Burroughs. (2013) Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis. Journal of Hepatology 58:3, pages 479-487.
Crossref
Simona Bota. (2013) Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review. World Journal of Hepatology 5:3, pages 120.
Crossref
Kyung Hoon KimByoung Kuk JangWoo Jin ChungJae Seok HwangYoung Oh KweonWon Young TakHeon Ju LeeChang Hyeong LeeJeong Ill Suh. (2011) Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis. The Korean Journal of Hepatology 17:3, pages 220.
Crossref
Mazen Noureddin & Marc G Ghany. (2010) Editorial : Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward Treatment. American Journal of Gastroenterology 105:10, pages 2174-2176.
Crossref
Hong Ryeol CheongHyun Young WooJeong HeoKi Tae YoonDong Uk KimGwang Ha KimDae Hwan KangGeun Am SongMong Cho. (2010) Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection. The Korean Journal of Hepatology 16:1, pages 38.
Crossref
Toshiro Ogata & Masayoshi Kage. (2010) Reconsideration of splenectomy for cirrhotic patients -Tracing the history and pitfalls-. Kanzo 51:5, pages 205-218.
Crossref
E. G. Giannini, M. Basso, V. Savarino & A. Picciotto. (2009) Predictive value of on‐treatment response during full‐dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension. Journal of Internal Medicine 266:6, pages 537-546.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.